Contraceptive devices and methods

US9421121B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9421121-B2
Application numberUS-201313859629-A
CountryUS
Kind codeB2
Filing dateApr 9, 2013
Priority dateOct 23, 2009
Publication dateAug 23, 2016
Grant dateAug 23, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Contraceptive devices that provide substantially immediate and permanent sterilization are described herein. Systems and methods for transcervically delivering the contraceptive devices are also described herein. The contraceptive device may include an expandable implant. The implant includes hydrogel to provide substantially immediate sterilization, and tissue in-growth fibers to provide permanent sterilization. As an alternative or in combination to hydrogel, the implant may include copper or cupric ions to provide substantially immediate sterilization. The implant may also include hydrogel to improve trackability of the implant through an ovarian pathway.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system for delivering an occlusion device to a body lumen comprising: a catheter having a distal end and a proximal end, the catheter comprising a sheath; an occlusion device releasably coupled with the catheter, the occlusion device comprising hydrogel; a hydrophilic material substantially coating the sheath, wherein a distal end of the occlusion device extends beyond a distal end of the catheter while the sheath protects the hydrogel from swelling upon exposure of the distal end of the catheter to a physiological environment; and a hydrophobic material that is a coating at the distal end of the catheter, wherein the hydrophobic material is piercable by the occlusion device to deliver the occlusion device through the distal end of the catheter. 2. The system of claim 1 , wherein the occlusion device comprises a primary coil structure having an outer coil and an inner coil coaxial with the outer coil, the primary coil structure being laterally flexible, the outer coil being self-expandable from a constrained configuration. 3. The system of claim 2 , further comprising a non-traumatic tip attached to the primary coil structure at a distal joint. 4. The system of claim 3 , further comprising a core wire extending to the distal joint, wherein stiffness of a distal portion of the core wire increases proximally. 5. The system of claim 4 , wherein the hydrophilic material is biodegradable in the physiological environment and the hydrogel swells responsive to at least a portion of the hydrophilic material dissolving and the hydrogel being exposed to the physiological environment. 6. The system of claim 3 , wherein the hydrogel is disposed adjacent to the distal joint. 7. The system of claim 3 , wherein the distal joint is a solder joint. 8. The system of claim 3 , wherein the non-traumatic tip includes a slight preformed bend. 9. The system of claim 2 , wherein the hydrogel is a preformed hollow cylinder that concentrically surrounds the inner coil. 10. The system of claim 9 , wherein the preformed hollow cylinder is attached to the inner coil with a glue. 11. The system of claim 2 , further comprising tissue in-growth promoting fibers disposed between the outer coil and the inner coil. 12. The system of claim 1 , wherein the hydrophobic material is dissolvable. 13. The system of claim 1 , wherein the hydrophobic material encapsulates a length of the occlusion device. 14. A method of delivering an occlusion device to a body lumen comprising: delivering a catheter to a body lumen, the catheter comprising a sheath and having an occlusion device releasably coupled with the catheter, the occlusion device comprising hydrogel, wherein a hydrophilic material substantially coats the sheath, a distal end of the occlusion device extends beyond a distal end of the catheter while the sheath protects the hydrogel from swelling upon exposure of the distal end of the catheter to a physiological environment in the body lumen and a hydrophobic material that is a coating at the distal end of the catheter or a membrane coating the distal end of the catheter; pushing the occlusion device through the sheath at the distal end of the catheter, wherein the occlusion device pierces the hydrophobic material to deliver the occlusion device through the distal end of the catheter; and expanding the occlusion device in the body lumen. 15. The method of claim 14 , wherein further comprising allowing the hydrogel to expand to block the body lumen after pushing the occlusion device through the catheter. 16. The method of claim 14 , further comprising allowing tissue ingrowth promoting fibers in the occlusion device to incite a reaction in the body lumen to block the body lumen. 17. The method of claim 14 , further comprising allowing the hydrophilic material to biodegrade in the physiological environment. 18. The method of claim 14 , wherein the hydrophobic material encapsulates a length of the occlusion device. 19. The method of claim 14 , further comprising allowing the hydrophobic material to dissolve. 20. The method of claim 14 , wherein the hydrophobic material is the membrane covering the distal end of the catheter. 21. A system for delivering an occlusion device to a body lumen comprising: a catheter having a distal end and a proximal end, the catheter comprising a sheath; an occlusion device releasably coupled with the catheter, the occlusion device comprising hydrogel; a hydrophilic material substantially coating the sheath, wherein a distal end of the occlusion device extends beyond a distal end of the catheter while the sheath protects the hydrogel from swelling upon exposure of the distal end of the catheter to a physiological environment; and a hydrophobic material that is a membrane covering the distal end of the catheter, wherein the hydrophobic material is pierceable by the occlusion device to deliver the occlusion device through the distal end of the catheter.

Assignees

Inventors

Classifications

  • A61F6/225Primary

    transcervical · CPC title

  • characterised by the location of the occluder · CPC title

  • Operations on Fallopian tubes, e.g. sterilization (A61B2017/1125 takes precedence) · CPC title

  • Occluding by internal devices, e.g. balloons or releasable wires (plugging an opening in the wall of an organ A61B17/0057; occluders for the cervical canal A61F6/146; vas deferens occluders A61F6/20) · CPC title

  • characterised by valve means · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9421121B2 cover?
Contraceptive devices that provide substantially immediate and permanent sterilization are described herein. Systems and methods for transcervically delivering the contraceptive devices are also described herein. The contraceptive device may include an expandable implant. The implant includes hydrogel to provide substantially immediate sterilization, and tissue in-growth fibers to provide perma…
Who is the assignee on this patent?
Bayer Healthcare Llc
What technology area does this patent fall under?
Primary CPC classification A61F6/225. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).